Innovative AI-Based Rapid Testing for Viral Infections

A new AI-driven nanopore test enables quick and accurate detection of live viruses within minutes, promising to enhance viral infection diagnosis and treatment.
Researchers have developed a groundbreaking non-DNA based diagnostic test that can detect viral infections within minutes. Traditionally, confirming the presence of a virus involves DNA sequencing tests, which, although accurate, take several hours and cannot determine whether the detected virus is viable. This new method, described in a recent study published in PNAS Nexus, offers a faster alternative by analyzing virus particles as they pass through a nanopore, measuring their electrical conductivity, size, surface charge, and molecular structure.
The test utilizes an AI-powered system that interprets electrical conductivity waveforms, enabling it to identify different viruses, even distinguishing among viruses within the same family. In trials focused on herpesvirus infections that can cause ocular diseases leading to blindness, the AI nanopore system achieved a sensitivity of 100%, with specificity improving over time to more than 90% under optimized conditions.
This technology has promising implications for rapid viral diagnosis, especially in ocular conditions and potentially other infectious diseases. As it matures, it could significantly enhance clinicians' ability to quickly detect and treat viral infections, ultimately improving patient outcomes.
The study was conducted by Noriyasu Hashida and colleagues, highlighting how this innovative approach could transform infectious disease diagnostics in clinical settings.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Childhood Antibiotic Use and Its Connection to Earlier Puberty in Girls
Research links antibiotic use during infancy to an increased risk of earlier puberty onset in girls, stressing the importance of cautious antibiotic prescribing for infants.
Understanding the Declining Effectiveness of Common Type 2 Diabetes Medications
New research explains why common type 2 diabetes medications like sulfonylureas lose effectiveness over time, highlighting the role of beta cell identity loss and potential for reversibility.
FDA Study Finds High Doses of Consumer CBD May Increase Liver Enzymes
A new FDA study indicates that high doses of consumer CBD, around 400 mg daily, may elevate liver enzymes in healthy adults, underscoring the need for careful monitoring and further safety research.
Major Recall: Over 67,000 Cases of Power Stick Deodorant Sold at Major Retailers
Over 67,000 cases of Power Stick deodorant sold at Dollar Tree, Walmart, and Amazon have been recalled due to manufacturing safety concerns. Consumers are advised to dispose of or return affected products.



